The 20 Best Neuroepithelioma Doctors Near Me in Round Rock, TX

Dr. Harvey is a board-certified neurosurgeon with fellowship training in complex spine surgery. He also completed a one-year fellowship in neurosurgical oncology at The University of Texas MD Anderson Cancer Center in Houston. Dr. Harvey's area of special focus is the treatment of brain and spine tumors with additional interest in spinal cord trauma. He is an Arizona native who received his medical degree from the Arizona College of Osteopathic Medicine at Midwestern University in Glendale before completing his residency training in neurosurgery at the University of Illinois in Bloomington. As part of his residency, Harvey completed his complex spine fellowship at the University of Illinois Peoria. In addition to practicing medicine, he is a Major in the United States Army Reserve Medical Corps. He speaks Finnish and some Spanish. Dr. Harvey is rated as an Experienced provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Subdural Hematoma, Chronic Subdural Hematoma, Delirium, Awake Craniotomy, and Vertebroplasty.

Dr. Cyrus Wong is board-certified by the American Board of Neurological Surgery and a Fellow of the American Association of Neurological Surgeons (FAANS). After previously serving for years as the Division Chief of Neurosurgery at Texas Health Harris Methodist Hospital Fort Worth, he is currently Chair of the Department of Neurosciences, overseeing the three divisions of Neurosurgery, Neurology, and Neuro-Intensive care. Dr. Wong is also the longstanding Medical Director of Spinal Deformity and Complex Spine Surgery. In addition, he is a member of Texas Health Fort Worth’s Medical Executive Committee and Operations Cabinet, and previously served on its Ethics Council. Dr. Wong is involved in neurosurgical research and medical education as Assistant Professor at Texas Christian University School of Medicine and has been recognized as a “Top Doc” in Neurosurgery by Fort Worth Magazine and 360West Magazine over multiple years.Dr. Wong completed his residency in neurosurgery and fellowship training in complex spinal surgery at Vanderbilt University Medical Center in Nashville. He received his medical degree from the Johns Hopkins University School of Medicine in Baltimore, Maryland, where he played a part in the development of a novel brainstem tumor model.Dr. Wong has authored several chapters in widely published textbooks and presented at national and international conferences on the topic of spinal disease and its treatment. His unique expertise in spinal surgery includes the treatment of adult spinal deformity/scoliosis, complex spinal reconstruction, spinal tumors, as well as minimally invasive spine surgery. He also treats benign and malignant brain tumors.Dr. Wong is a Diplomate of the American Board of Neurological Surgery and a Fellow Member of the American Association of Neurological Surgeons (AANS), as well as a member of the Congress of Neurological Surgeons (CNS), AANS/CNS Joint Spine Section, AO Spine, and the North American Spine Society. Dr. Wong is rated as an Experienced provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Subdural Hematoma, Scoliosis, Chronic Subdural Hematoma, Laminectomy, and Microdiscectomy.

Dr. Joseph Quillin believes that the practice of neurosurgery is a tremendous privilege. His focus is on durable symptom relief, patient quality of life, maximum safe tumor resection, and the prevention of further neurological damage for his patients. His advanced training in brain, spine, and skull base/cerebrovascular disorders has enabled him to care for some of the most complex patients in neurosurgery. Dr. Quillin specializes in neurosurgical oncology and skull base surgery, using techniques such as radiotherapy and minimally invasive endoscopic surgery to promote tumor treatment and removal. He has served the DFW area since 2021.Dr. Quillin earned his medical degree at Louisiana State University Health Sciences Center in Shreveport. He completed his neurological surgery residency and fellowship training in neurological oncology at Emory University in Atlanta, Georgia. He also completed additional fellowship training in skull base/cerebrovascular surgery at Rutgers University in New Brunswick, N.J. Away from the office, Dr. Quillin has served as an ad hoc reviewer for publications including NEUROSURGERY, World Neurosurgery, and the Journal of Neuro-Oncology. He is a member of the American Association of Neurological Surgeons and Congress of Neurological Surgeons. Dr. Quillin is rated as an Experienced provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Meningioma, Pituitary Tumor, Chiari Malformation Type 1, Endoscopic Transnasal Transsphenoidal Surgery, and Awake Craniotomy.

Dr. Moneeb Ehtesham is a fellowship-trained neurosurgeon with specialized expertise in cerebrovascular/endovascular neurosurgery and complex spinal surgery. He has served in teaching and senior academic research and leadership capacities for over two decades. Dr. Ehtesham currently serves as an Associate Professor at the TCU Burnett School of Medicine. His areas of special focus include open and endovascular surgery for aneurysms and other cerebrovascular conditions as well as spinal surgery. Additionally, he has been recognized for his research in the areas of stem cell therapies and brain tumors. He was a recipient of the Young Investigator Award from the American Association of Neurological Surgeons and Congress of Neurological Surgeons.Dr. Ehtesham completed his neurological surgery residency at Vanderbilt University Medical Center in Nashville, where he served as chief resident in his final year. He also completed his neurointerventional/ endovascular neurosurgery fellowship at Vanderbilt. Dr. Ehtesham is a Diplomate of the American Board of Neurological Surgery and a Fellow of the American Association of Neurological Surgeons and the American College of Surgeons. Dr. Ehtesham is rated as an Experienced provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Subarachnoid Hemorrhage, Stroke, Subdural Hematoma, Laminectomy, and Stent Placement.

Neurosurgeon Anita Bhansali, M.D., is fellowship-trained in functional neurosurgery from the esteemed Swedish Neuroscience Institute, which is a leader in the comprehensive clinical care of neurological disorders. She is a Fellow of the American Association of Neurological Surgeons. Dr. Bhansali's areas of specialization include the evaluation and treatment of functional neurosurgical disorders such as epilepsy, movement disorders, and pain syndromes. Her additional areas of special interest and focus include the treatment of cervical spine instability and degenerative spine disease, and deep brain and nerve stimulation for Parkinson's disease and other neurological conditions.Dr. Bhansali earned her medical degree at the University of Washington School of Medicine in Seattle. She completed her neurological surgery residency at the University of Chicago Medical Center in Illinois before going on to complete her fellowship training at the Swedish Neuroscience Institute, also in Seattle. She is published in numerous medical journals and publications on a wide variety of topics in neurosurgery. Dr. Bhansali is rated as an Experienced provider by MediFind in the treatment of Neuroepithelioma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Subarachnoid Hemorrhage, Chronic Subdural Hematoma, Delirium, Deep Brain Stimulation, and Gastrostomy.

"Dr. Olaide Ajayi is board-certified by the American Board of Neurological Surgeons and is a Fellow of the American Association of Neurological Surgeons. He is the Medical Director of Spine Surgery at Texas Health Harris Methodist Hospital in Fort Worth.Dr. Ajayi completed his Neurosurgery Residency as well as a Complex and Minimally Invasive Spine Fellowship at Loma Linda University Medical Center in Southern California. He also received his Medical Doctorate from the same institution. He has authored and contributed to many peer review publications on various neurosurgical and spine related topics.His areas of special focus include the surgical management of degenerative scoliosis, spine tumors, spine trauma, complex and minimally invasive spine surgery, and degenerative spine disease. Dr. Ajayi takes a comprehensive approach in the management of spinal disease, utilizing conservative treatment options when feasible, as well as minimally invasive and complex reconstructive approaches when necessary.Dr. Ajayi is a member of the North American Spine Society (NASS), American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS) and AANS/CNS Joint Spine Section.WATCH NOW:</h5>Patient Testimonial: North Texas Neurosurgical & Spine Center (Dr. Ajayi)</a>". Dr. Ajayi is rated as an Experienced provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Subdural Hematoma, Chronic Subdural Hematoma, Delirium, Microdiscectomy, and Herniated Disc Surgery.

Karen Fink, MD, PhD, is the Medical Director of Clinical Neuro-Oncology Research at Baylor University Medical Center.  Dr. Fink leads our neuro-oncology team, heading the multi-disciplinary Baylor Scott and White Sammons Cancer Center brain tumor board and multiple clinical trials for patients with brain tumors. She has a long history of involvement in advanced clinical trials in collaboration with industry groups and with prominent neuro-oncology programs nationwide. Dr. Fink received her undergraduate degree in biochemistry from Washington University in St. Louis, Missouri. She then completed her MD and PhD at the Mayo Clinic in Rochester, Minnesota, where she investigated early cellular activation of cancer-causing genes in response to growth signals. Her Neurology residency and Neuro-oncology fellowship were accomplished at UT Southwestern Medical Center in Dallas. She stayed there after completing her training, becoming the Director of Clinical Neuro-Oncology. She moved to Baylor University Medical Center to found Neuro-Oncology Associates in 2006. At Baylor Scott & White, she continued to offer clinical trials as an investigator in the North American Brain Tumor Consortium, and later, the Brain Tumor trials Collaborative spearheaded at the National Institute of Health. She still works with pharmaceutical and device companies to offer advanced treatments for patients with brain tumors. Dr. Fink has participated in over 50 neuro-oncology clinical trials, been an author on over 50 peer reviewed publications, and over 80 abstracts covering various aspects of Neuro-Oncology research. She mentors Neurology Residents, Oncology fellows and medical students, instilling knowledge regarding the management of primary brain tumor patients and providing an example of compassionate and up-to-date clinical care. Dr. Fink has formally served as a member of the Corporate Compliance Committee and the Multidisciplinary Cancer Committee at Baylor Scott and White. She is a member of the Society for Neuro-Oncology and the American Society of Clinical Oncology. Dr. Fink specializes in the treatment of tumors in the brain, central nervous system, and peripheral nervous system. She collaborates with Neuro-Oncology clinicians and their medical teams in north and central Texas, and with Neurosurgeons, Radiation Oncologists, Medical Oncologists, Neuro-Radiologists and Palliative Care clinicians across the region to coordinate complete care for patients and their loved ones who are dealing with a brain tumor. Dr. Fink has been named one of Texas Monthly's Texas Super Doctors for over 10 years earning her a place on Texas Monthly's Hall of Fame list. Read more about Dr. Fink’s research publications on PubMed.gov. Dr. Fink is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Fink is board certified in Neurology- American Board Of Psychiatry And Neurology/Neurology and Neurology- American Board Of Psychiatry And Neurology.

Toral Patel is a Neurosurgery provider practicing medicine in Dallas, Texas. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. She is also highly rated in 41 other conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, Awake Craniotomy, and Gamma Knife Radiosurgery.

Jacob Mandel, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Jacob Mandel specializes in Neurology (Brain and Spine) and works at BCM Neurology. To make an appointment, please call (713) 798-2273. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Mandel is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Mandel is board certified in Neurology From The American Board Of Psychiatry And Neurology, Neuro-Oncology From The American Board Of Psychiatry And Neurology, American Academy Of Neurology, Society Of Neuro-Oncology, American Society Of Clinical Oncology. Dr. Mandel is currently accepting new patients.

An American Board of Radiology Certified Radiation Oncologist, Dr. Goble has been with the CHI St. Joseph Health Cancer Center since 1996. A graduate of the University of Louisville, School of Medicine, he served his residency in Radiation Oncology at the University of Kansas Medical Center. Dr. Goble is a member of the American Medical Association, American Society for Radiation Oncology, Texas Medical Association, Brazos-Robertson Co. Medical Society, American College of Radiation Oncology, American College of Radiology, and the Texas Radiological Society. In addition to private practice, Dr. Goble is currently Clinical Assistant Professor in the Department of Radiology at the Texas A&M Health Science Center College of Medicine. Dr. Goble devotes himself to ongoing research and study that keeps him on the leading edge of cancer treatment through radiation. Dr. Goble is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Familial Prostate Cancer, and Posterior Fossa Tumor. Dr. Goble is currently accepting new patients.

Ibrahim Shalaby is an Oncologist practicing medicine in Lubbock, Texas. Dr. Shalaby is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 53 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Pleuropulmonary Blastoma. Dr. Shalaby is currently accepting new patients.

Paul Derose is a Radiation Oncologist practicing medicine in Richardson, Texas. Dr. Derose is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Gliosarcoma, Embryonal Tumor with Multilayered Rosettes, and Neuroepithelioma. Dr. Derose is board certified in Radiation Oncology- American Board Of Radiology/Radiation Oncology and Radiation Oncology- American Board Of Radiology.

Alan Trumbly is an Oncologist practicing medicine in Richardson, Texas. Dr. Trumbly is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Familial Colorectal Cancer, Gliosarcoma, Embryonal Tumor with Multilayered Rosettes, and Bone Marrow Aspiration. Dr. Trumbly is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

David Close is an Oncologist practicing medicine in Lubbock, Texas. Dr. Close is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 60 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Breast Cancer, and Familial Colorectal Cancer. Dr. Close is currently accepting new patients.

Terry Jenkins, MD, is dedicated to delivering high-quality, compassionate care to Bryan and nearby communities. Terry Jenkins specializes in Oncology and works at Cancer Clinic. To make an appointment, please call (979) 776-2000. Dr. Jenkins is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Gliosarcoma, Embryonal Tumor with Multilayered Rosettes, Neuroepithelioma, and Bone Marrow Aspiration. Dr. Jenkins is currently accepting new patients.

Dr. Jay-Jiguang Zhu is a fellowship-trained, board-certified neurologist with specific expertise in neuro-oncology and neurology. He specializes in treating patients with primary brain tumors and central nervous system (CNS) metastasis. Dr. Zhu earned his medical degree from McGill University in Montreal, Quebec, Canada. He completed his residency training in neurology at Tufts University School of Medicine in Boston, Mass. He subsequently completed his fellowship in neuro­oncology at Massachusetts General Hospital, Harvard Medical School in Boston. Prior to entering medical school, Dr. Zhu received his doctorate in molecular biology at State University of New York in Buffalo, N.Y., and completed his post-doctoral training in CNS tumorigenesis research at Children’s Hospital, Brigham and Woman’s Hospital, Harvard Medical School. Before joining Mischer Neuroscience Institute, Dr. Zhu was on the faculty of Tufts Medical Center and Tufts University School of Medicine where he served as an assistant professor and attending in neurology, hematology and oncology. His many honors and awards include CUSBEA scholar (China and United States Biochemistry Exchange Application), Massachusetts Medical Society Scholarships, the Abby H. Shevitz, M.D. Young Physician award, and Teaching Award from the class of 2002 at Tufts University School of Medicine. Dr. Zhu is dedicated to delivering exceptional patient care through multidisciplinary teamwork. He is committed to providing patients the best treatment options available and to maximizing each patient’s quality of life. Through collaboration with clinicians and research scientists, he will combine clinical data with sophisticated molecular assays and powerful imaging techniques to formulate individualized treatment plans and develop new treatment options for primary brain tumors and CNS metastasis. Dr. Zhu’s special interests include: Primary brain tumors (gliomas, meningiomas, pituitary adenomas and primary CNS lymphomas) Brain metastases and leptomeningeal spread of systemic cancers Quality of life, including cognitive function during and after radiation and chemotherapies Clinical trials Neurological complications of systemic chemotherapies. Dr. Zhu is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Glioblastoma, and Gliosarcoma.

Dr. Sigmund Hsu is fellowship trained and certified by the American Board of Psychiatry and Neurology, with extensive experience in the evaluation and treatment of neurological disorders in cancer patients. He specializes in primary brain tumors as well as brain and spinal cord metastases, cancer neurology and the treatment of chemotherapy neurotoxicity. Dr. Hsu earned both his undergraduate and medical degrees from Brown University in Providence, Rhode Island. He completed his medical internship at the Hospital of St. Raphael at Yale University in New Haven, Connecticut, where he was awarded medical intern of the year in 1996. After his residency at Weill Cornell Medical Center in New York, with Fred Plum, MD, and Jerome Posner, MD, Dr. Hsu completed his fellowship training in neuro-oncology at The University of Texas MD Anderson Cancer Center. Prior to joining the Mischer Neuroscience Institute, Dr. Hsu was on the faculty at MD Anderson, where he served as assistant professor of neuro-oncology and the neurology residency program director. He is a charter member of the Brain Tumor Network and has volunteered for several years for Run for the Rose, serving as the medical director from 2005-07. Dr. Hsu has presented research at several national conferences, and his work has been published in numerous journals and textbooks. His most recent research has focused on novel therapies for recurrent primary CNS lymphoma, recurrent glioblastoma multiforme and intralumbar injections for cancer therapy, and he has several patents granted and pending for his treatments. Dr. Hsu’s expertise includes treatment of the following: Cancer neurology Chemotherapy neurotoxicity Leptomeningeal metastases Meningeal malignancies Recurrent glioblastoma multiforme. Dr. Hsu is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Dr. Nitin Tandon has special expertise in the surgical management of medically refractory epilepsy as well as functional mapping and resection of glial neoplasms. A professor of neurosurgery at McGovern Medical School, Dr. Tandon received his medical degree at the Armed Forces Medical College in Pune, India, followed by a residency in neurosurgery at The University of Texas Health Science Center in San Antonio. He completed a fellowship in epilepsy surgery at the Cleveland Clinic and has been in practice since 2003 at Memorial Hermann-Texas Medical Center and on faculty at McGovern Medical School during that time. He has performed more than 3000 cranial operations, with over 1200 cranial operations for brain tumors and 700 cranial operations for the treatment of epilepsy. He has performed more than 200 craniotomies on patients who are awake for the purpose of mapping and preserving eloquent brain regions. He has co-authored many studies, which have been published in basic science journals such as Nature Neuroscience, Cerebral Cortex, Journal of Neuroscience, Journal of Neurosurgery, NeuroImage and Human Brain Mapping. His research studies focus on multi-modality assessments of cognitive functions combining intracranial recordings, functional MRI and direct cortical stimulation. He is funded by multiple grants from the NIH and the NSF to study and modulate brain networks involved in language, memory, prefrontal control and epilepsy. Most recently, he received a UO1 grant from the NIH BRAIN initiative, to probe the mechanisms of reading in the human brain. Dr. Tandon is a member of the Texas Medical Association, American Association of Neurological Surgeons, Organization of Human Brain Mapping, Society for Neuroscience, and the American Epilepsy Society. He is a member of the editorial board of Operative Neurosurgery and an ad hoc reviewer for many peer-reviewed journals. He routinely serves as a reviewer on NIH study sections. He has been an invited speaker at national and international conferences. More information about his research effort is at tandonlab.org. Dr. Tandon is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Epilepsy, Seizures, Glioblastoma, Awake Craniotomy, and Deep Brain Stimulation.

Dr. Yoshua Esquenazi is a neurosurgeon with fellowship training in epilepsy surgery and surgical neuro-oncology. He focuses his practice on brain and spine tumors. Dr. Esquenazi received his medical degree at the Universidad Anahuac in Mexico City, graduating as valedictorian. During his studies he participated in student exchange rotations at Harvard Medical School and Massachusetts General Hospital and Brigham and Women’s Hospital, as well as the William J. Harrington Medical Training Programs for Latin America at the University of Miami School of Medicine. He completed a general surgery internship at the Mayo Clinic in Rochester, MN and his neurosurgery residency training at the McGovern Medical School at UTHealth, where he was neurosurgery chief resident and recipient of the Alpha Omega Alpha Honor Medical Society (Delta Chapter) Resident Award and the Standing Ovation Award from Memorial Hermann-Texas Medical Center. During residency he worked in the medical school’s Neuroimaging and Electrophysiology Lab and then went on to complete a fellowship in epilepsy surgery at the same institution under Nitin Tandon, M.D. He subsequently completed a neurosurgery oncology fellowship at Memorial Sloan Kettering Cancer Center in New York City. He is an author of numerous book chapters and articles, and he received numerous awards and recognitions during his academic training. Dr. Esquenazi integrates techniques such as brain mapping for awake craniotomies, stereotactic laser ablation, intraventricular endoscopy, stereotactic navigation and fluorescent microscopy to enhance safety during surgery and maximize tumor removal. He is fluent in Spanish and specializes in the following conditions and treatments. Brain metastases CNS lymphoma Endoscopic management of hydrocephalus and colloid cysts Gamma Knife® radiosurgery High-grade gliomas (glioblastoma) Insular gliomas Intraventricular tumors Low-grade gliomas (astrocytomas, oligodendrogliomas) Intradural spinal tumors Malignant spinal column tumors (metastatic spine tumors) Meningiomas Pineal region and brainstem tumors Pituitary and parasellar tumors Primary brain tumors in speech, motor, visual and sensory areas Primary spinal cord tumors Spine stereotactic radiosurgery (SBRT). Dr. Esquenazi is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Radiation Induced Meningioma, Awake Craniotomy, and Gastrostomy.

Sanjay Oommen is a Hematologist and an Oncologist practicing medicine in Fort Worth, Texas. Dr. Oommen is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, Lymphofollicular Hyperplasia, and Bone Marrow Aspiration. Dr. Oommen is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology, Hematology- American Board Of Internal Med/Hematology, Medical Oncology- American Board Of Internal Medicine, Hematology- American Board Of Internal Medicine, and Internal Medicine- American Board Of Internal Medicine.